MoneyWorks4Me

Anuh Pharma - Quaterly Results

11 Aug 2023 Evaluate
The sales moved up 38.76% to Rs. 1614.81 millions for the June 2023 quarter as compared to Rs. 1163.77 millions during the year-ago period.Profit after tax for the quarter ended June 2023 reported a huge growth of 60.23% to Rs. 117.53  millions from Rs. 73.35 millions.Operating Profit saw a handsome growth to 174.45 millions from 121.40 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1614.81 1163.77 38.76 1614.81 1163.77 38.76 5274.86 4866.46 8.39
Other Income 34.70 9.55 263.35 34.70 9.55 263.35 61.15 51.97 17.66
PBIDT 174.45 121.40 43.70 174.45 121.40 43.70 573.90 520.43 10.27
Interest 0.22 0.60 -63.33 0.22 0.60 -63.33 2.18 9.61 -77.32
PBDT 174.23 120.80 44.23 174.23 120.80 44.23 571.72 510.82 11.92
Depreciation 20.09 24.18 -16.91 20.09 24.18 -16.91 97.00 119.60 -18.90
PBT 154.14 96.62 59.53 154.14 96.62 59.53 474.72 391.22 21.34
TAX 36.61 23.27 57.33 36.61 23.27 57.33 112.91 85.61 31.89
Deferred Tax 0.01 -1.33 -100.75 0.01 -1.33 -100.75 -8.29 -9.95 -16.68
PAT 117.53 73.35 60.23 117.53 73.35 60.23 361.81 305.61 18.39
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 10.80 10.43 3.56 10.80 10.43 3.56 10.88 10.69 1.74
Peers
Company Name CMP
Sun Pharma. Inds. 1836.80
Dr. Reddys Labs. 1159.00
Cipla 1353.30
Lupin 2082.15
Zydus Lifesciences 1117.00
View more..